Effectiveness of a Multi-Component Smoking Cessation Support Programme (McSCSP) for Patients with Severe Mental Disorders: Study Design
Only a few studies have examined the efficacy and safety of smoking cessation programmes in patients with mental disorders. The aim of this paper is to describe in detail the methodology used in the study as well as the Multi-component Smoking Cessation Support Programme in terms of pharmacological...
Main Authors: | , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2013-12-01
|
Series: | International Journal of Environmental Research and Public Health |
Subjects: | |
Online Access: | http://www.mdpi.com/1660-4601/11/1/373 |
id |
doaj-1e950f3c157f493e8e9859518474bce1 |
---|---|
record_format |
Article |
spelling |
doaj-1e950f3c157f493e8e9859518474bce12020-11-24T23:19:32ZengMDPI AGInternational Journal of Environmental Research and Public Health1660-46012013-12-0111137338910.3390/ijerph110100373ijerph110100373Effectiveness of a Multi-Component Smoking Cessation Support Programme (McSCSP) for Patients with Severe Mental Disorders: Study DesignMaria Paz Garcia-Portilla0Leticia Garcia-Alvarez1Pilar Alejandra Saiz2Eva Diaz-Mesa3Gonzalo Galvan4Fernando Sarramea5Josefa Garcia-Blanco6Edorta Elizagarate7Julio Bobes8Departmento de Psiquiatría, Universidad de Oviedo, 33006 Oviedo, SpainCentro de Investigación Biomédica en Red de Salud Mental, CIBERSAM, Universidad de Oviedo, 33006 Oviedo, SpainDepartmento de Psiquiatría, Universidad de Oviedo, 33006 Oviedo, SpainCentro de Investigación Biomédica en Red de Salud Mental, CIBERSAM, Universidad de Oviedo, 33006 Oviedo, SpainUniversidad Nacional de la Patagonia Austral, Puerto San Julián, 9310 Santa Cruz, ArgentinaComplejo Hospitalario de Jaén, Equipo de Salud Mental de Andújar, 23740 Jaén, SpainComplejo Hospitalario de Jaén, Equipo de Salud Mental de Andújar, 23740 Jaén, SpainUnidad de Psicosis Refractarias, Hospital Psiquiátrico de Álava, 01006 Vitoria, SpainDepartmento de Psiquiatría, Universidad de Oviedo, 33006 Oviedo, SpainOnly a few studies have examined the efficacy and safety of smoking cessation programmes in patients with mental disorders. The aim of this paper is to describe in detail the methodology used in the study as well as the Multi-component Smoking Cessation Support Programme in terms of pharmacological treatments and psychological interventions. An open-label 9-month follow-up study was conducted in Spain. A total of 82 clinically stable outpatients with schizophrenia, schizoaffective or bipolar disorder were enrolled. Treatment consisted of a programme specifically developed by the research team for individuals with severe mental disorders. The programme consisted of two phases: (1) weekly individual motivational therapy for 4–12 weeks, and (2) a 12-week active treatment phase. During this phase, at each study visit patients received a one- or two-week supply of medication (transdermal nicotine patches, varenicline or bupropion) with instructions on how to take it, in addition to group psychotherapy for smoking cessation. Evaluations were performed: (1) at the time of enrolment in the study, (2) during the 12-week active treatment phase of the study (weekly for the first 4 weeks and then biweekly), and (3) after the end of this phase (two follow-up assessments at weeks 12 and 24). Evaluations included: (1) smoking history, (2) substance use, (3) psychopathology, (4) adverse events, and (5) laboratory tests. The importance of this study lies in addressing a topical issue often ignored by psychiatrists: the unacceptably high rates of tobacco use in patients with severe mental disorders.http://www.mdpi.com/1660-4601/11/1/373schizophreniabipolar disordertransdermal nicotine patchesvareniclinebupropion |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Maria Paz Garcia-Portilla Leticia Garcia-Alvarez Pilar Alejandra Saiz Eva Diaz-Mesa Gonzalo Galvan Fernando Sarramea Josefa Garcia-Blanco Edorta Elizagarate Julio Bobes |
spellingShingle |
Maria Paz Garcia-Portilla Leticia Garcia-Alvarez Pilar Alejandra Saiz Eva Diaz-Mesa Gonzalo Galvan Fernando Sarramea Josefa Garcia-Blanco Edorta Elizagarate Julio Bobes Effectiveness of a Multi-Component Smoking Cessation Support Programme (McSCSP) for Patients with Severe Mental Disorders: Study Design International Journal of Environmental Research and Public Health schizophrenia bipolar disorder transdermal nicotine patches varenicline bupropion |
author_facet |
Maria Paz Garcia-Portilla Leticia Garcia-Alvarez Pilar Alejandra Saiz Eva Diaz-Mesa Gonzalo Galvan Fernando Sarramea Josefa Garcia-Blanco Edorta Elizagarate Julio Bobes |
author_sort |
Maria Paz Garcia-Portilla |
title |
Effectiveness of a Multi-Component Smoking Cessation Support Programme (McSCSP) for Patients with Severe Mental Disorders: Study Design |
title_short |
Effectiveness of a Multi-Component Smoking Cessation Support Programme (McSCSP) for Patients with Severe Mental Disorders: Study Design |
title_full |
Effectiveness of a Multi-Component Smoking Cessation Support Programme (McSCSP) for Patients with Severe Mental Disorders: Study Design |
title_fullStr |
Effectiveness of a Multi-Component Smoking Cessation Support Programme (McSCSP) for Patients with Severe Mental Disorders: Study Design |
title_full_unstemmed |
Effectiveness of a Multi-Component Smoking Cessation Support Programme (McSCSP) for Patients with Severe Mental Disorders: Study Design |
title_sort |
effectiveness of a multi-component smoking cessation support programme (mcscsp) for patients with severe mental disorders: study design |
publisher |
MDPI AG |
series |
International Journal of Environmental Research and Public Health |
issn |
1660-4601 |
publishDate |
2013-12-01 |
description |
Only a few studies have examined the efficacy and safety of smoking cessation programmes in patients with mental disorders. The aim of this paper is to describe in detail the methodology used in the study as well as the Multi-component Smoking Cessation Support Programme in terms of pharmacological treatments and psychological interventions. An open-label 9-month follow-up study was conducted in Spain. A total of 82 clinically stable outpatients with schizophrenia, schizoaffective or bipolar disorder were enrolled. Treatment consisted of a programme specifically developed by the research team for individuals with severe mental disorders. The programme consisted of two phases: (1) weekly individual motivational therapy for 4–12 weeks, and (2) a 12-week active treatment phase. During this phase, at each study visit patients received a one- or two-week supply of medication (transdermal nicotine patches, varenicline or bupropion) with instructions on how to take it, in addition to group psychotherapy for smoking cessation. Evaluations were performed: (1) at the time of enrolment in the study, (2) during the 12-week active treatment phase of the study (weekly for the first 4 weeks and then biweekly), and (3) after the end of this phase (two follow-up assessments at weeks 12 and 24). Evaluations included: (1) smoking history, (2) substance use, (3) psychopathology, (4) adverse events, and (5) laboratory tests. The importance of this study lies in addressing a topical issue often ignored by psychiatrists: the unacceptably high rates of tobacco use in patients with severe mental disorders. |
topic |
schizophrenia bipolar disorder transdermal nicotine patches varenicline bupropion |
url |
http://www.mdpi.com/1660-4601/11/1/373 |
work_keys_str_mv |
AT mariapazgarciaportilla effectivenessofamulticomponentsmokingcessationsupportprogrammemcscspforpatientswithseverementaldisordersstudydesign AT leticiagarciaalvarez effectivenessofamulticomponentsmokingcessationsupportprogrammemcscspforpatientswithseverementaldisordersstudydesign AT pilaralejandrasaiz effectivenessofamulticomponentsmokingcessationsupportprogrammemcscspforpatientswithseverementaldisordersstudydesign AT evadiazmesa effectivenessofamulticomponentsmokingcessationsupportprogrammemcscspforpatientswithseverementaldisordersstudydesign AT gonzalogalvan effectivenessofamulticomponentsmokingcessationsupportprogrammemcscspforpatientswithseverementaldisordersstudydesign AT fernandosarramea effectivenessofamulticomponentsmokingcessationsupportprogrammemcscspforpatientswithseverementaldisordersstudydesign AT josefagarciablanco effectivenessofamulticomponentsmokingcessationsupportprogrammemcscspforpatientswithseverementaldisordersstudydesign AT edortaelizagarate effectivenessofamulticomponentsmokingcessationsupportprogrammemcscspforpatientswithseverementaldisordersstudydesign AT juliobobes effectivenessofamulticomponentsmokingcessationsupportprogrammemcscspforpatientswithseverementaldisordersstudydesign |
_version_ |
1725578544209199104 |